ClinConnect ClinConnect Logo
Search / Trial NCT02039999

An Investigation Into the Mechanism of Inhalation Cough Challenge

Launched by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST · Jan 16, 2014

Trial Information

Current as of April 29, 2025

Completed

Keywords

Chronic Cough Challenge Atp Hypersensitivity Trpa1

ClinConnect Summary

The investigators have previously demonstrated that mild acids, such as citric, tartaric or phosphoric acid produce a highly reliable cough challenge and that the sensitivity of these are complex individual acids correlates within the population studied inferring a common mechanism of action.In contrast there is no correlation with the other common cough challenge methodology, capsaicin inferring that there are at least two different mechanisms for producing cough with aerosols in man.

Over the past 10 years it has been established that capsaicin works by a specific irritant receptor known...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients will be required to demonstrate significant cough symptoms by a score greater than 20/70 on the Hull Airways Reflux Questionnaire.
  • All patients must be current non-smokers.
  • Patients must be on stable medication for at least one month.
  • Patients must be able to attend the trials unit on at least 3 occasions.
  • Patients must have normal lung function patients must be able to give informed consent
  • Exclusion Criteria:
  • Subjects who are pregnant, or have pacemakers in situ are excluded from this study.
  • Those with a serious comorbid conditions such as cancer, severe COPD, or heart failure will be excluded.
  • Those who are non-English speakers and special groups (i.e. mentally ill, children under 16 years of age, and those suffering from dementia) will be excluded.
  • No test will be performed on any subject during an acute worsening of asthma or upper airway infection. If the subject has had an upper airway infection in the last three weeks they will be offered another appointment.
  • If the subject has taken any over the counter (OTC) cough mixture within the last twelve hours: If the subject is willing to come back another time for challenge testing, another appointment should be made.
  • If the subject has had any food or drink products containing caffeine or menthol within the last hour. If the subject is unwilling to wait for 1 hour before starting the test, the subject should return another time. If the subject is unwilling to return another time, testing should proceed and the medication used recorded.
  • If the participant is currently involved in research, or within 3 months of participation in any type of research, they will be excluded from this study.

About Hull University Teaching Hospitals Nhs Trust

Hull University Teaching Hospitals NHS Trust is a leading healthcare organization dedicated to delivering high-quality patient care, education, and research. Located in Hull, England, the Trust encompasses a range of hospitals and healthcare services, providing a comprehensive spectrum of clinical specialties. With a strong commitment to advancing medical science, the Trust actively sponsors and conducts clinical trials that aim to improve patient outcomes and contribute to evidence-based practice. By collaborating with academic partners and leveraging its state-of-the-art facilities, Hull University Teaching Hospitals NHS Trust fosters an innovative research environment that prioritizes patient safety and ethical standards.

Locations

Cottingham, East Yorkshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Alyn H Morice, MD, FRCP

Principal Investigator

National Health Service, United Kingdom

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials